Active 0 6 0 6 B-chronic_disease
ulcerative 7 17 7 17 I-chronic_disease
colitis 18 25 18 25 I-chronic_disease
with 26 30 26 30 O
an 31 33 31 33 O
Adapted 34 41 34 41 B-clinical_variable
Mayo 42 46 42 46 I-clinical_variable
score 47 52 47 52 I-clinical_variable
of 53 55 53 55 O
5 56 57 56 57 B-lower_bound
to 58 60 58 60 O
9 61 62 61 62 B-upper_bound
points 63 69 63 69 O

Appropriate 0 11 70 81 O
documentation 12 25 82 95 O
of 26 28 96 98 O
biopsy 29 35 99 105 B-treatment
results 36 43 106 113 O
consistent 44 54 114 124 O
with 55 59 125 129 O
the 60 63 130 133 O
diagnosis 64 73 134 143 O
of 74 76 144 146 O
UC 77 79 147 149 B-chronic_disease
, 79 80 149 150 O
in 81 83 151 153 O
the 84 87 154 157 O
assessment 88 98 158 168 O
of 99 101 169 171 O
the 102 105 172 175 O
Investigator 106 118 176 188 O
, 118 119 188 189 O
must 120 124 190 194 O
be 125 127 195 197 O
available 128 137 198 207 O

Current 0 7 208 215 O
diagnosis 8 17 216 225 O
of 18 20 226 228 O
fulminant 21 30 229 238 B-chronic_disease
colitis 31 38 239 246 I-chronic_disease
and/or 39 45 247 253 O
toxic 46 51 254 259 B-chronic_disease
megacolon 52 61 260 269 I-chronic_disease

Diagnosis 0 9 270 279 O
of 10 12 280 282 O
ulcerative 13 23 283 293 B-chronic_disease
colitis 24 31 294 301 I-chronic_disease
for 32 35 302 305 O
90 36 38 306 308 B-lower_bound
days 39 43 309 313 I-lower_bound
or 44 46 314 316 O
greater 47 54 317 324 O
prior 55 60 325 330 O
to 61 63 331 333 O
Baseline 64 72 334 342 O
, 72 73 342 343 O
confirmed 74 83 344 353 O
by 84 86 354 356 O
colonoscopy 87 98 357 368 O
during 99 105 369 375 O
the 106 109 376 379 O
Screening 110 119 380 389 O
Period 120 126 390 396 O

Female 0 6 397 403 B-gender
participants 7 19 404 416 O
of 20 22 417 419 O
childbearing 23 35 420 432 O
potential 36 45 433 442 O
must 46 50 443 447 O
have 51 55 448 452 O
a 56 57 453 454 O
negative 58 66 455 463 O
serum 67 72 464 469 O
pregnancy 73 82 470 479 O
test 83 87 480 484 O
at 88 90 485 487 O
the 91 94 488 491 O
Screening 95 104 492 501 O
Visit 105 110 502 507 O
and 111 114 508 511 O
a 115 116 512 513 O
negative 117 125 514 522 O
urine 126 131 523 528 O
pregnancy 132 141 529 538 O
test 142 146 539 543 O
at 147 149 544 546 O
the 150 153 547 550 O
Baseline 154 162 551 559 O
Visit 163 168 560 565 O
prior 169 174 566 571 O
to 175 177 572 574 O
study 178 183 575 580 O
drug 184 188 581 585 O
dosing 189 195 586 592 O

If 0 2 593 595 O
female 3 9 596 602 B-gender
, 9 10 602 603 O
participant 11 22 604 615 O
must 23 27 616 620 O
meet 28 32 621 625 O
the 33 36 626 629 O
criteria 37 45 630 638 O
for 46 49 639 642 O
Contraception 50 63 643 656 O
Recommendations 64 79 657 672 O

Participant 0 11 673 684 O
on 12 14 685 687 O
azathioprine 15 27 688 700 B-treatment
or 28 30 701 703 O
6 31 32 704 705 B-treatment
- 32 33 705 706 I-treatment
mercaptopurine 33 47 706 720 I-treatment
within 48 54 721 727 O
10 55 57 728 730 B-upper_bound
days 58 62 731 735 I-upper_bound
of 63 65 736 738 O
baseline 66 74 739 747 O

Participant 0 11 748 759 O
with 12 16 760 764 O
current 17 24 765 772 O
diagnosis 25 34 773 782 O
of 35 37 783 785 O
Crohn 38 43 786 791 B-chronic_disease
's 43 45 791 793 I-chronic_disease
disease 46 53 794 801 I-chronic_disease
( 54 55 802 803 I-chronic_disease
CD 55 57 803 805 I-chronic_disease
) 57 58 805 806 I-chronic_disease

Participant 0 11 807 818 O
with 12 16 819 823 O
disease 17 24 824 831 O
limited 25 32 832 839 O
to 33 35 840 842 O
the 36 39 843 846 O
rectum 40 46 847 853 O
( 47 48 854 855 O
ulcerative 48 58 855 865 B-chronic_disease
proctitis 59 68 866 875 I-chronic_disease
) 68 69 875 876 O
during 70 76 877 883 O
the 77 80 884 887 O
Screening 81 90 888 897 O
endoscopy 91 100 898 907 B-treatment

Received 0 8 908 916 O
cyclosporine 9 21 917 929 B-treatment
, 21 22 929 930 O
tacrolimus 23 33 931 941 B-treatment
, 33 34 941 942 O
mycophenolate 35 48 943 956 B-treatment
mofetil 49 56 957 964 I-treatment
, 56 57 964 965 O
or 58 60 966 968 O
thalidomide 61 72 969 980 B-treatment
within 73 79 981 987 O
30 80 82 988 990 B-upper_bound
days 83 87 991 995 I-upper_bound
prior 88 93 996 1001 I-upper_bound
to 94 96 1002 1004 O
Baseline 97 105 1005 1013 O

Received 0 8 1014 1022 O
intravenous 9 20 1023 1034 B-treatment
corticosteroids 21 36 1035 1050 I-treatment
within 37 43 1051 1057 O
14 44 46 1058 1060 B-upper_bound
days 47 51 1061 1065 I-upper_bound
prior 52 57 1066 1071 I-upper_bound
to 58 60 1072 1074 O
Screening 61 70 1075 1084 O
or 71 73 1085 1087 O
during 74 80 1088 1094 O
the 81 84 1095 1098 O
Screening 85 94 1099 1108 O
Period 95 101 1109 1115 O

biologic 0 8 1116 1124 B-treatment
therapies 9 18 1125 1134 I-treatment
in 19 21 1135 1137 O
the 22 25 1138 1141 O
opinion 26 33 1142 1149 O
of 34 36 1150 1152 O
the 37 40 1153 1156 O
investigator 41 53 1157 1169 O

corticosteroids 0 15 1170 1185 B-treatment

diagnosis 0 9 1186 1195 O
of 10 12 1196 1198 O
indeterminate 13 26 1199 1212 B-chronic_disease
colitis 27 34 1213 1220 I-chronic_disease
( 35 36 1221 1222 I-chronic_disease
IC 36 38 1222 1224 I-chronic_disease
) 38 39 1224 1225 I-chronic_disease

immunosuppressants 0 18 1226 1244 B-treatment

meet 0 4 1245 1249 O
the 5 8 1250 1253 O
definition 9 19 1254 1264 O
of 20 22 1265 1267 O
Tanner 23 29 1268 1274 B-clinical_variable
Stage 30 35 1275 1280 I-clinical_variable
5 36 37 1281 1282 I-clinical_variable
at 38 40 1283 1285 O
Screening 41 50 1286 1295 O
Visit 51 56 1296 1301 O

oral 0 4 1302 1306 B-treatment
aminosalicylates 5 21 1307 1323 I-treatment

weigh 0 5 1324 1329 B-clinical_variable
> 6 7 1330 1331 O
= 7 8 1331 1332 O
40 9 11 1333 1335 B-lower_bound
kilograms 12 21 1336 1345 I-lower_bound

